Reminder: Invitation to Roche’s Virtual Investor Event at EASD

Roche will host a virtual investor event on September 13, 2024, to present data from the European Association for the Study of Diabetes 2024 Meeting. The event will feature presentations on Roche's obesity and diabetes pipeline, specifically CT-388 and CT-996. Manu Chakravarthy, SVP and Global Head of Cardiovascular, Renal and Metabolism (CVRM) Product Development, will lead the presentations and Q&A session. The slides will be available for download at the start of the event. Pre-registration for the webinar is required. Those unable to register due to company policy should contact Roche Investor Relations. A replay of the webcast will be available on Roche's investor relations website. Roche Investor Relations can be reached by phone or email.